Abstract P216 Table 1
NLCA data
Local data
Male:female
1.4:1
0.86:1
Histological confirmation
68%
89%
Stage IV at presentation in NSCLC
32%
55%
Active treatment received
51%
86%
Resection in NSCLC
14%
17%
Median NSCLC survival (day)
232
246